Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asako Takei

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cerebellum (London, England)|September 9, 2005
Treatment of cerebellar ataxia with 5-HT1A agonistAsako Takei, Takeshi Hamada, Ichiro Yabe, et al.
Psychiatry and Clinical Neurosciences|November 25, 2003
'Drug holiday' effects of tandospirone in a patient with Machado-Joseph diseaseAsako Takei, Toshiyuki Fukazawa, Takeshi Hamada, et al.
Journal of Neurology|December 14, 2004
No association between FMR1 premutations and multiple system atrophyIchiro Yabe, Hiroyuki Soma, Asako Takei, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2007
Dropped head sign as the only symptom of myasthenia gravisHiroaki Yaguchi, Asako Takei, Sanae Honma, et al.
Journal of Neurology|November 24, 2016
Cognitive dysfunction in patients with spinocerebellar ataxia type 6Itaru Tamura, Asako Takei, Shinsuke Hamada, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genesHiroyuki Soma, Ichiro Yabe, Asako Takei, et al.
Journal of the Neurological Sciences|November 26, 2005
Heredity in multiple system atrophyHiroyuki Soma, Ichiro Yabe, Asako Takei, et al.
Cerebellum (London, England)|September 3, 2010
Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label studyAsako Takei, Shinsuke Hamada, Sanae Homma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2009
Amelioration of subacute camptocormia in multiple system atrophy by protirelin tartrateAsako Takei, Shinsuke Hamada, Sanae Homma, et al.
Journal of the Neurological Sciences|July 11, 2006
MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSAIchiro Yabe, Hiroyuki Soma, Asako Takei, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cerebellum (London, England)|September 9, 2005
Treatment of cerebellar ataxia with 5-HT1A agonistAsako Takei, Takeshi Hamada, Ichiro Yabe, et al.
Psychiatry and Clinical Neurosciences|November 25, 2003
'Drug holiday' effects of tandospirone in a patient with Machado-Joseph diseaseAsako Takei, Toshiyuki Fukazawa, Takeshi Hamada, et al.
Journal of Neurology|December 14, 2004
No association between FMR1 premutations and multiple system atrophyIchiro Yabe, Hiroyuki Soma, Asako Takei, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2007
Dropped head sign as the only symptom of myasthenia gravisHiroaki Yaguchi, Asako Takei, Sanae Honma, et al.
Journal of Neurology|November 24, 2016
Cognitive dysfunction in patients with spinocerebellar ataxia type 6Itaru Tamura, Asako Takei, Shinsuke Hamada, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genesHiroyuki Soma, Ichiro Yabe, Asako Takei, et al.
Journal of the Neurological Sciences|November 26, 2005
Heredity in multiple system atrophyHiroyuki Soma, Ichiro Yabe, Asako Takei, et al.
Cerebellum (London, England)|September 3, 2010
Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label studyAsako Takei, Shinsuke Hamada, Sanae Homma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2009
Amelioration of subacute camptocormia in multiple system atrophy by protirelin tartrateAsako Takei, Shinsuke Hamada, Sanae Homma, et al.
Journal of the Neurological Sciences|July 11, 2006
MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSAIchiro Yabe, Hiroyuki Soma, Asako Takei, et al.
Pageof 3